Pausing Use of the Johnson & Johnson/Janssen COVID-19 Vaccine

April 16, 2021

Updates as of April 23, 2021: Effective April 23, 2021, CDC and FDA recommend that use of the Johnson & Johnson/Janssen COVID-19 Vaccine resume in the United States. However, women younger than 50 years old should be made aware of a rare risk of blood clots with low platelets following vaccination and the availability of…

Read More